|
|
Volumn 7, Issue 5, 2001, Pages 337-353
|
|
Type II topoisomerases as targets for quinolone antibacterials: Turning Dr. Jekyll into Mr. Hyde
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (3 AMINO 1 PYRROLIDINYL) 2 FLUORO 4 OXO 4H QUINO[8,1A,1 B,C][1,4]BENZOXAZINE 5 CARBOXYLIC ACID;
1 ETHYL 6,8 DIFLUORO 1,4 DIHYDRO 4 OXO 7 (4 PYRIDYL) 3 QUINOLINECARBOXYLIC ACID;
A 65281;
AMSACRINE;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
CIPROFLOXACIN;
CP 115 953;
CP 67 804;
DNA TOPOISOMERASE (ATP HYDROLYSING);
DNA TOPOISOMERASE IV;
DOUBLE STRANDED DNA;
DOXORUBICIN;
ETOPOSIDE;
GATIFLOXACIN;
GENISTEIN;
GREPAFLOXACIN;
LEVOFLOXACIN;
MOXIFLOXACIN;
NALIDIXIC ACID;
NORFLOXACIN;
OFLOXACIN;
OXOLINIC ACID;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SPARFLOXACIN;
TROVAFLOXACIN;
UNCLASSIFIED DRUG;
WIN 58161;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
CELL CULTURE;
CELL KILLING;
CONTROLLED STUDY;
DNA STRAND BREAKAGE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TARGETING;
ENZYME ACTIVITY;
EUKARYOTE;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
IN VIVO STUDY;
INFECTION;
MAMMAL CELL;
NONHUMAN;
PRIORITY JOURNAL;
SPECIES DIFFERENCE;
TUMOR MODEL;
4-QUINOLONES;
ANTI-INFECTIVE AGENTS;
ANTINEOPLASTIC AGENTS;
DNA DAMAGE;
DNA TOPOISOMERASE IV;
DNA TOPOISOMERASES, TYPE II;
GRAM-NEGATIVE BACTERIA;
GRAM-POSITIVE BACTERIA;
|
|
EID: 0035042602
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/1381612013398013 Document Type: Article |
|
Times cited : (153)
|
|
References (151)
|
